Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.90M | 18.01M | 17.22M | 16.31M | 15.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.90M | 18.01M | 17.22M | 16.31M | 15.30M |
| Cost of Revenue | 6.70M | 5.86M | 5.06M | 4.68M | 4.26M |
| Gross Profit | 12.20M | 12.15M | 12.17M | 11.64M | 11.04M |
| SG&A Expenses | 12.71M | 12.35M | 12.05M | 11.57M | 11.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.24M | 3.30M | 3.38M | 3.35M | 3.30M |
| Total Operating Expenses | 24.74M | 23.79M | 22.96M | 22.14M | 21.18M |
| Operating Income | -5.84M | -5.78M | -5.74M | -5.83M | -5.88M |
| Income Before Tax | -5.89M | -5.76M | -5.65M | -5.72M | -5.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.89 | -5.76 | -5.65 | -5.72 | -5.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.89M | -5.76M | -5.65M | -5.72M | -5.76M |
| EBIT | -5.84M | -5.78M | -5.74M | -5.83M | -5.88M |
| EBITDA | -4.40M | -4.09M | -3.79M | -3.87M | -3.91M |
| EPS Basic | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 989.34M | 941.80M | 894.27M | 855.42M | 816.56M |
| Average Diluted Shares Outstanding | 989.34M | 941.80M | 894.27M | 855.42M | 816.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |